West Pharmaceutical Services WST recently announced the global commercial availability of the West Synchrony S1 prefillable syringe (PFS) system at Pharmapack 2026 in Paris, France. The new system ...

Long-term follow-up data from a phase 2b trial of Moderna and MSD's mRNA-based vaccine against melanoma, intismeran autogene (mRNA-4157), show an impressive 49% reduction in the risk of disease ...

West Pharmaceutical Services just saw its fair value estimate nudged slightly, with the price target essentially steady at about US$345.71 per share, while the discount rate and revenue growth inputs ...

TMC the metals company Inc. ("TMC" or the "Company"), a leading developer of the world's largest resource of critical metals essential to energy, defense, manufacturing and infrastructure, today ...

PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech” or the "Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...

Application is the first consolidated exploration license and commercial recovery permit application submitted under NOAA's new consolidated application and review process-which the Company expects wi ...

Murphy Oil Corporation today announced results from the Civette exploration well in Block CI-502 offshore Côte d'Ivoire. The Civette-1X well reached a total depth of 13,950 feet (4,252 meters) and ...

PDS Biotechnology Corporation (Nasdaq: PDSB) ("PDS Biotech" or the "Company"), a late-stage immunotherapy company focused on transforming how the immune ...

Washington, DCViXC today announced the release of its latest platform version, introducing a unified environment for ...

The Justice Department on Friday released more documents from the Jeffrey Epstein files, more than a month after the original ...

Our credit quality is strong and for the quarter continued to improve as our nonperforming loan ratio decreased 8 basis points to 39 basis points. This ratio compares favorably relative to our peer ...